November/December 2012

Conventional and Biologic Rheumatoid Arthritis Therapies: Utilization and Cost Trends

December 12, 2012

The American Journal of Pharmacy Benefits

Based on American College of Rheumatology recommendations and novel emerging treatment options, the trend of increasing biologic use for rheumatoid arthritis is expected to continue.

The Global Fight for a Healthier World

December 12, 2012

The American Journal of Pharmacy Benefits

Last year's historic UN meeting set the stage for the fight against noncommunicable diseases. What are our next steps in stopping this slow-moving hurricane?

New Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation

December 11, 2012

The American Journal of Pharmacy Benefits

This review summarizes the safety and efficacy of 3 new orally active anticoagulant drugs (dabigatran, rivaroxaban, apixaban) that can be used as alternatives to warfarin.

Pharmaceutical Compounding Versus Manufacturing: Renewed Interest in an Old Question

December 11, 2012

The American Journal of Pharmacy Benefits

The New England Compounding Center experience points to an immediate need for clarification of exactly where the dividing line is between compounding and pharmaceutical manufacturing.